|

Melphalan through Percutaneous Hepatic Perfusion Clinical Trials

1 actively recruiting trial across 1 location

Top Sponsors

  • Massachusetts General Hospital1

Indications

  • Liver Disease1
  • Uveal Melanoma1
  • Liver Cancer1
  • Cancer1

Boston, Massachusetts1 trial

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Massachusetts General Hospital

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.